IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis

Journal of Infection

Volumn 66, Issue 6, 2013, Pages 475-486

  Petruccioli, Elisa ^a   Petrone, Linda ^a   Vanini, Valentina ^a   Sampaolesi, Alessandro ^a   Gualano, Gina ^a   Girardi, Enrico ^a   Palmieri, Fabrizio ^a   Goletti, Delia ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Active tuberculosis; CD4; Cured tuberculosis; Latent tuberculosis; M. tuberculosis; Memory profile; Polyfunctional T cells; Quantiferon; RD1; Tuberculosis

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE COURSE; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; IN VITRO STUDY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; QUALITATIVE ANALYSIS; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; ANTIGENS, BACTERIAL; ANTIGENS, VIRAL; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; MALE; MIDDLE AGED; PHENOTYPE; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876836834     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.02.004     Document Type: Article

References (36)

1. WHO Report 2012 http://www.who.int/tb/publications/global_report/en/.
2. Ottenhoff T.H. New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol 2012, 20:419-428.
3. Cooper A.M., Magram J., Ferrante J., Orme I.M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med 1997, 186:39-45.
4. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993, 178:2249-2254.
5. Jouanguy E., Lamhamedi-Cherradi S., Lammas D., Dorman S.E., Fondaneche M.C., Dupuis S., et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 1999, 21:370-378.
6. Keane J., Gershon S., Wise R.P., Mirabile-Levens E., Kasznica J., Schwieterman W.D., et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001, 345:1098-1104.
7. + T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest 2009, 119:1167-1177.
8. Kannanganat S., Ibegbu C., Chennareddi L., Robinson H.L., Amara R.R. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J Virol 2007, 81:8468-8476.
9. + T cells. Blood 2006, 107:4781-4789.
10. + T-cell immune correlates against HIV. Immunol Rev 2011, 239:109-124.
11. Ciuffreda D., Comte D., Cavassini M., Giostra E., Buhler L., Perruchoud M., et al. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol 2008, 38:2665-2677.
12. Darrah P.A., Patel D.T., De Luca P.M., Lindsay R.W., Davey D.F., Flynn B.J., et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007, 13:843-850.
13. Chiacchio T., Petruccioli E., Vanini V., Butera O., Cuzzi G., Petrone L., et al. Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood. PLoS One 2011, 6:e27539.
14. + T cells at sites of pleural TB. Tuberculosis (Edinb) 2011, 91:224-230.
15. Millington K.A., Innes J.A., Hackforth S., Hinks T.S., Deeks J.J., Dosanjh D.P., et al. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 2007, 178:5217-5226.
16. Sargentini V., Mariotti S., Carrara S., Gagliardi M.C., Teloni R., Goletti D., et al. Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis 2009, 9:99.
17. Sester U., Fousse M., Dirks J., Mack U., Prasse A., Singh M., et al. Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states. PLoS One 2011, 6:e17813.
18. + T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis. PLoS One 2012, 7:e36046.
19. Caccamo N., Guggino G., Joosten S.A., Gelsomino G., Di Carlo P., Titone L., et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 2010, 40:2211-2220.
20. Commandeur S., Lin M.Y., van Meijgaarden K.E., Friggen A.H., Franken K.L., Drijfhout J.W., et al. Double- and monofunctional CD4(+) and CD8(+) T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals. Eur J Immunol 2011, 41:2925-2936.
21. Day C.L., Abrahams D.A., Lerumo L., Janse van Rensburg E., Stone L., O'rie T., et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol 2011, 187:2222-2232.
22. + T cell responses discriminate between latent infection and active disease. Nat Med 2011, 17:372-376.
23. Sutherland J.S., Adetifa I.M., Hill P.C., Adegbola R.A., Ota M.O. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 2009, 39:723-729.
24. Young J.M., Adetifa I.M., Ota M.O., Sutherland J.S. Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment. PLoS One 2010, 5:e11237.
25. + memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis 2006, 194:984-992.
26. Lanzavecchia A., Sallusto F. Understanding the generation and function of memory T cell subsets. Curr Opin Immunol 2005, 17:326-332.
27. Butera O., Chiacchio T., Carrara S., Casetti R., Vanini V., Meraviglia S., et al. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect Dis 2009, 9:182.
28. +, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF. Cytokine 2008, 43:143-148.
29. Wang X., Cao Z., Jiang J., Niu H., Dong M., Tong A., et al. Association of mycobacterial antigen-specific CD4(+) memory T cell subsets with outcome of pulmonary tuberculosis. J Infect 2010, 60:133-139.
30. Roederer M., Nozzi J.L., Nason M.C. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 2011, 79:167-174.
31. Gideon H.P., Flynn J.L. Latent tuberculosis: what the host "sees"?. Immunol Res 2011, 50:202-212.
32. Forbes E.K., Sander C., Ronan E.O., McShane H., Hill A.V., Beverley P.C., et al. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol 2008, 181:4955-4964.
33. Hawkridge T., Scriba T.J., Gelderbloem S., Smit E., Tameris M., Moyo S., et al. Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J Infect Dis 2008, 198:544-552.
34. + T cells. Eur J Immunol 2010, 40:279-290.
35. Shin H., Wherry E.J. CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 2007, 19:408-415.
36. Schuetz A., Haule A., Reither K., Ngwenyama N., Rachow A., Meyerhans A., et al. Monitoring CD27 expression to evaluate Mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo. PLoS One 2011, 6:e27284.